BMS-813160

• Description :

  BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  484.64

• Molecular Formula :

  C25H40N8O2

• Notes :

  Research use only, not for human use.

• Receptor :

  CCR2|CCR5

• CAS Number :

  1286279-29-5